Publication
Research Article
International Journal of MS Care
Author(s):
Multiple sclerosis (MS) causes motor, cognitive, and sensory impairments that result in injurious falls. Current fall risk measures in MS (ie, forward walking [FW] speed and balance) are limited in their sensitivity. Backward walking (BW) velocity is a sensitive marker of fall risk and correlates with information processing speed (IPS) and visuospatial memory (VSM) in persons with MS. Backward walking is a complex motor task that requires increased cognitive demands, which are negatively affected by MS; however, whether cognitive function modifies the sensitivity of BW as a fall risk assessment in MS remains unknown. This study examines the influence of cognition on the relationship between BW and falls in persons with MS.
Measures of BW, FW, IPS, VSM, and retrospective falls were collected. Hierarchical regression tested moderation and included an interaction term predicting number of falls. Covariates for all analyses included age and disease severity.
Thirty-eight persons with MS participated. Although BW, IPS, and covariates significantly predicted the number of falls (R 2 = 0.301; P = .016), there was no evidence of moderation. Backward walking, VSM, and covariates also significantly predicted number of falls (R 2 = 0.332, P = .008), but there was no evidence of moderation. The FW models generated comparable results.
The relationship between BW velocity and falls was not conditional on IPS or VSM in this sample. Larger-scale studies examining additional cognitive domains commonly affected by MS and prospective falls are needed to characterize neurobiological processes relevant to BW and its clinical application in the assessment of fall risk.
Multiple sclerosis (MS) is a progressive neurologic disease associated with inflammation, demyelination and axonal damage that leads to debilitating motor and cognitive impairments.1 Consequently, injurious falls are common in persons with MS, with more than 50% of individuals experiencing a fall in a 3-month period.2 Falls in MS are associated with decreased quality of life (activity curtailment and social isolation)2,3 and greater cost to society (increased demand on health care resources).4
Current fall risk measures rely on forward walking (FW) speed,5 balance,5 and past falls4; however, these measures exhibit limited sensitivity to predict fall risk,6–8 which may be attributed to their inability to detect subtle underlying impairments that are linked to falls, including motor and cognitive dysfunction. At present, a simple and sensitive fall detection measure remains unidentified for persons with MS.4
Substantial evidence supports backward walking (BW) velocity as a reliable fall prediction measure in the elderly and other neurologic populations.9–11 Recently, our laboratory examined the relationship between BW and falls in persons with MS to determine what clinical measures of walking and disability most strongly and uniquely differentiate those with MS who fall from those with MS who do not fall.5 Velocity of BW exhibited the highest effect magnitude and specificity in differentiating the 2 groups compared with standard clinical methods. The present findings emphasize the importance of examining BW as a quick, simple, and sensitive fall prediction tool in persons with MS. However, critical gaps in knowledge remain in our understanding of BW’s ability to sensitively detect falls in persons with MS, and it remains unclear whether functional domains commonly affected by MS may modify the sensitivity of BW as a fall risk assessment in MS.
Backward walking is a complex, novel task requiring increased postural control, lower extremity strength, and sensory and cognitive demands,12,13 all of which are negatively affected by and related to falls in MS.14,15 The relationships between BW, motor function, and falls in persons with MS are established,5,16–18 yet the relationship between BW, cognitive function, and falls in persons with MS is unknown. Previous MS research demonstrates connections between complex motor task performance and the function of specific cognitive domains, namely, information processing speed (IPS) and visuospatial memory (VSM).19,20 Similarly, our laboratory has shown that BW correlates with IPS21 and VSM (N. Fritz, PhD, DPT, PT, NCS; M. Atalla, BS; M. Nitta, BS; unpublished data; 2018). However, the aforementioned cognitive studies did not examine falls. Thus, the relationship between BW, cognitive function, and falls remains unknown in persons with MS. This leaves a critical gap in knowledge regarding cognitive mechanisms underlying BW’s ability to detect falls.
Based on published preliminary data, we hypothesized that the relationship between BW velocity and falls is conditional on an individual’s IPS, and a secondary hypothesis tested VSM (FIGURE 1A). Evidence in support of these hypotheses is the critical first step in establishing a cognitive framework aimed at characterizing neurobiological processes relevant to BW and its clinical application in the assessment of fall risk and targeted fall prevention therapies for persons with MS.
Analytic Framework and Findings
A convenience sample of 38 participants with a neurologist-confirmed diagnosis of relapsing-remitting MS was recruited from the MS clinic at Wayne State University in Detroit, Michigan, and from local MS support groups of the greater Detroit area. All participants provided written informed consent, and the research protocol was approved by the Wayne State University institutional review board. Individuals with MS were eligible to participate if they were between 18 and 75 years old, stable on immunomodulatory therapy (if applicable) for at least 3 months before the beginning of the study, ambulatory with or without physical assistance, and able to follow study-related commands. Exclusion criteria included MS exacerbation within the past 8 weeks, corticosteroid use within the past 30 days, and acute orthopedic or other neurologic conditions that would interfere with walking.
Demographic data were collected, including age, sex, body mass index, disease severity (using the Patient-Determined Disease Steps [PDDS] scale), and symptom duration.
The FW and BW performance was evaluated using a 16-ft GAITRite electronic walkway (CIR Systems, Inc). The GAITRite electronic walkway is equipped with sensors organized in a gridlike pattern that record footfalls in real time and is reliable and valid for use in MS.22 The GAITRite calculates spatiotemporal measures of gait and individual step parameters. Participants were instructed to walk at their quickest and safest speed for FW trials, which mimics the conditions of the Timed 25-Foot Walk test. Participants were instructed to walk at a comfortable, safe pace for BW trials, following the methods of our laboratory and others.11,21 Four trials were recorded for each condition, and the data were averaged. Participants received instruction to look ahead rather than at their feet, wore a gait belt, and were accompanied by a research assistant to ensure safety and minimize path deviations on all trials.
Processing speed was assessed using the Symbol Digit Modalities Test (SDMT). Participants received a key with 9 numbers each corresponding to a symbol and were asked to determine the number belonging with a series of symbols using this key. The score is the number of correct answers in 90 seconds. The SDMT is validated and reliable in MS to analyze IPS.23 Visuospatial memory was assessed using the Brief Visuospatial Memory Test–Revised (BVMT-R). Participants are shown 6 simple figures arranged in a 2×3 matrix on 8×11 paper for 3 consecutive 10-second trials. After each trial, participants were asked to draw as many shapes as accurately as possible and in the correct location. The BVMT-R demonstrates good psychometric properties and high reliability in MS.24
Falls were measured retrospectively: Participants were asked, “How many times have you fallen in the last month?” and answered with a number. Falls were defined as “unexpected events that resulted in an unintentional landing on the ground or a lower surface.”25
All statistical analyses were performed using IBM SPSS Statistics for Windows version 25.0 (IBM Corp). We chose, a priori, to evaluate IPS and VSM because both domains are primarily affected by MS and have been linked to BW velocity and falls, separately, in persons with MS.5,15 To evaluate the hypothesis that the relationship between BW velocity and falls is moderated by cognition, we used hierarchical regression modeling. The model’s first step used the main effects of BW and cognitive function to predict the number of falls, and significantly increased variance was used in the second step with the addition of an interaction term to test the moderation hypothesis. Continuous predictors were mean centered before model estimation. For each cognitive domain tested, we ran 1 model for BW and 1 model for FW, resulting in 4 total models; all significance testing was adjusted for multiple comparisons (Bonferroni corrected α = 0.01). Covariates for all analyses included age and disease severity as measured using the PDDS scale.
Thirty-eight participants (4 men and 34 women) with relapsing-remitting MS participated in this study. The mean ± SD patient age was 50.4 ± 9.2 years, symptom duration was 16.9 ± 11.8 years, and PDDS scale score was 3.2 ± 4 Most of the participants (86.8%) were taking disease-modifying therapies, and 39.5% used walking devices during testing (TABLE 1). There was no statistical evidence to suggest that IPS or VSM moderates the relationship between BW velocity and falls (FIGURE 1). In the first BW model (A1–2), BW velocity, IPS, and covariates (age and disease severity) significantly predicted the number of falls (R 2 = 0.301; P = .016) (FIGURE 1B). However, IPS did not change the relationship to BW velocity (ΔR 2 = 0.013; P > .1) (FIGURE 1C). In the second BW model (B1–2), BW velocity, VSM, and covariates also significantly predicted the number of falls (R 2 = 0.332; P = .008) (FIGURE 1D). However, VSM did not change the relationship to BW velocity (ΔR 2 = 0.001; P > .1) (FIGURE 1E). Both FW models (data not shown) for IPS and VSM generated comparable results.
Demographic Measures
This study’s critical finding was that the relationship between BW and falls was not dependent on IPS or VSM in this limited sample of persons with MS. Previous studies in MS acknowledge the link between deficits in complex motor tasks (ie, BW) and dysfunction in discrete cognitive domains (ie, IPS and VSM,19,20 which have also been linked to fall risk in MS6); however, falls are multifactorial and complex events. Therefore, in addition to cognition, many disease-driven (sensory dysfunction, muscle weakness, fatigue, spasticity) and/or environmental factors may influence the relationship between BW and falls in persons with MS. In addition, the average disability level of the sample was 3.2 (ie, low disability) (Table 1), as reflected by the PDDS scale score, and the average FW velocity was 1.6 m/s (Table 1), which is indicative of low fall risk according to clinically meaningful cutoff speeds.26 Thus, the lack of cognitive moderation observed in this sample may be attributed to relatively low overall disability and cognitive dysfunction. Alternatively, if no conditional effects are observed in future studies with a larger sample size, we can interpret BW as a sensitive fall risk tool across patients with MS, regardless of possible comorbid cognitive impairment.
Another critical finding is that the combination of BW velocity, cognitive function, and covariates significantly predicted the number of falls, consistent with previous literature in which BW has been linked to cognition16,21 and falls in persons with MS.5,18 However, the present findings provide only a limited snapshot of the factors that predict fall risk in persons with MS and do not provide sufficient detail into whether specific cognitive mechanisms underlie BW’s ability to predict falls. For example, we used only single measures of IPS (ie, SDMT) and VSM (ie, BVMT-R) when additional technology-adapted versions of these assessments exist to sensitively probe these discrete domains.27 Notably, the SDMT and BVMT-R, both part of the Brief International Cognitive Assessment for MS battery, were recently reported to demonstrate high sensitivity to cognitive impairment.28 Previous work in MS also demonstrates that IPS is the foundation for high-level cognitive processes because it affects downstream domains,29 yet, similar to all symptoms of MS, cognitive impairment is heterogenous in severity, progression, and the specific domains affected.30 Thus, examining and controlling for impairment in other domains primarily affected by MS is critical to develop a complete cognitive framework to support the clinical utility of BW as a sensitive fall detection tool in MS.
In this convenience sample, we relied on retrospective fall reports, which are subject to inaccuracy given the high prevalence of memory problems in persons with MS.3 Our future work will use wrist-worn activity sensors to report falls, establish the predictive validity of BW as a fall risk marker in MS, and control for physical activity levels. Next, we recognize that additional domains of cognition commonly affected by MS (ie, executive function and attention) and their relative influence on the relationship between BW and falls should be examined. This study did not incorporate neuroimaging techniques to better understand the contribution of motor and cognitive brain regions to BW and subsequent fall risk. Our future work will leverage innovative MRI techniques specific to myelin (ie, myelin water imaging) to develop a neurobiological basis supporting the clinical utility of BW as a fall detection measure in MS.
The relationship between BW velocity and falls was not conditional on IPS or VSM in this small sample of persons with MS. Confirmation of these results by larger-scale studies is warranted to understand whether an interaction between cognition and BW in predicting falls reflects underlying neurocognitive architecture or if BW’s ability to detect falls is not confounded by comorbid impairments in IPS or VSM. Future work examining additional cognitive domains affected by MS (ie, executive function and attention), prospective falls, and neuroimaging of motor and cognitive brain regions is needed to characterize neurobiological processes relevant to BW and its clinical application in the assessment of fall risk in persons with MS. Ultimately, advancements in this work will pave the way for sensitive fall detection measures and targeted fall prevention therapies, grounded by neuroscience, to improve clinical outcomes for persons with MS.
Fall risk in multiple sclerosis (MS) is related to multiple factors, including motor and cognitive deficits. Tests involving forward walking were shown to be of limited sensitivity in detecting fall risk.
Backward walking speed is a reliable predictor of falls in other neurologic populations, and we previously showed that backward walking speed differentiates people with MS who fall from people with MS who do not fall better than traditional measures.
Findings from this study suggest that the relationship between backward walking speed and falls is independent of performance on cognitive tests of information processing speed and visuospatial memory.
Backward walking could represent a quick, simple, and sensitive fall prediction tool in MS, although this needs to be confirmed in further studies.
Simmatis LE, Jin AY, Taylor SW, Bisson EJ, Scott SH, Baharnoori M. The feasibility of assessing cognitive and motor function in multiple sclerosis patients using robotics. Mult Scler J Exp Transl Clin. 2020;6(4):2055217320964940. doi: 10.1177/2055217320964940
Coote S, Sosnoff JJ, Gunn H. Fall incidence as the primary outcome in multiple sclerosis falls-prevention trials: recommendation from the International MS Falls Prevention Research Network. Int J MS Care. 2014;16(4):178–184. doi: 10.7224/1537-2073.2014-059
Matsuda PN, Shumway-Cook A, Ciol MA, Bombardier CH, Kartin DA. Understanding falls in multiple sclerosis: association of mobility status, concerns about falling, and accumulated impairments. Phys Ther. 2012;92(3):407–415. doi: 10.2522/ptj.20100380
Cameron MH, Thielman E, Mazumder R, Bourdette D. Predicting falls in people with multiple sclerosis: fall history is as accurate as more complex measures. Mult Scler Int. 2013;2013:496325. doi: 10.1155/2013/496325
Edwards EM, Daugherty AM, Nitta M, Atalla M, Fritz NE. Backward walking sensitively detects fallers in persons with multiple sclerosis. Mult Scler Relat Disord. 2020;45:102390. doi: 10.1016/j.msard.2020.102390
Gunn HJ, Newell P, Haas B, . Identification of risk factors for falls in multiple sclerosis: a systematic review and meta-analysis. Phys Ther. 2013;93(4):504–513. doi: 10.2522/ptj.20120231
Nilsagård Y, Gunn H, Freeman J, . Falls in people with MS: an individual data meta-analysis from studies from Australia, Sweden, United Kingdom, and the United States. Mult Scler. 2015;21(1):92–100. doi: 10.1177/1352458514538884
Quinn G, Comber L, Galvin R, Coote S. The ability of clinical balance measures to identify falls risk in multiple sclerosis: a systematic review and meta-analysis. Clin Rehabil. 2018;32(5):571–582. doi: 10.1177/0269215517748714
Fritz NE, Worstell AM, Kloos AD, Siles AB, White SE, Kegelmeyer DA. Backward walking measures are sensitive to age-related changes in mobility and balance. Gait Posture. 2013;37(4):593–597. doi: 10.1016/j.gaitpost.2012.09.022
Maritz CA, Silbernagel KG, Pohlig R. Relationship of backward walking to clinical outcome measures used to predict falls in the older population: a factor analysis. Phys Ther Rehabil. 2017;4:14. doi: 10.7243/2055-2386-4-14
Hackney ME, Earhart GM. Backward walking in Parkinson’s disease. Mov Disord. 2009;24(2):218–223. doi: 10.1002/mds.22330
Johansson H, Lundin-Olsson L, Littbrand H, Gustafson Y, Rosendahl E, Toots A. Cognitive function and walking velocity in people with dementia; a comparison of backward and forward walking. Gait Posture. 2017;58:481–486. doi: 10.1016/j.gaitpost.2017.09.009
Motl RW, Cohen JA, Benedict R, . Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis. Mult Scler. 2017;23(5):704–710. doi: 10.1177/1352458517690823
Sun R, Hsieh KL, Sosnoff JJ. Fall risk prediction in multiple sclerosis using postural sway measures: a machine learning approach. Sci Rep. 2019;9(1):16154. doi: 10.1038/s41598-019-52697-2
Kalron A. The relationship between specific cognitive domains, fear of falling, and falls in people with multiple sclerosis. Biomed Res Int. 2014;2014:281760. doi: 10.1155/2014/281760
Wajda DA, Sandroff BM, Pula JH, Motl RW, Sosnoff JJ. Walking direction and cognitive challenges on persons with multiple sclerosis. Mult Scler Int. 2013;2013:859323. doi: 10.1155/2013/859323
Peterson DS, Huisinga JM, Spain RI, Horak FB. Characterization of compensatory stepping in people with multiple sclerosis. Arch Phys Med Rehabil. 2015;97(4):513–552. doi: 10.1016/j.apmr.2015.10.103
Edwards EM, Kegelmeyer DA, Kloos AD, . Backward walking and dual-task assessment improve identification of gait impairments and fall risk in individuals with MS. Mult Scler Int. 2020;2020:6707414. doi: 10.1155/2020/6707414
Drew M, Tippett LJ, Starkey NJ, Isler RB. Executive dysfunction and cognitive impairment in a large community-based sample with multiple sclerosis from New Zealand: a descriptive study. Arch Clin Neuropsychol. 2008;23(1):1–19. doi: 10.1016/j.acn.2007.09.005
Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol. 2008;7(12):1139–1151. doi: 10.1016/S1474-4422(08)70259-X
Saymuah S, Laird H, Nitta M, Atalla M, Fritz N. Motor, cognitive, and behavioral performance in middle-aged and older adults with multiple sclerosis. Top Geriatr Rehabil. 2018;35(3):199–208. doi: 10.1097/TGR.0000000000000235
Givon U, Zeilig G, Achiron A. Gait analysis in multiple sclerosis: characterization of temporal-spatial parameters using GAITRite functional ambulation system. Gait Posture. 2009;29(1):138–142. doi: 10.1016/j.gaitpost.2008.07.011
Strober LB, Bruce JM, Arnett PA, . A new look at an old test: normative data of the symbol digit modalities test-oral version. Mult Scler Relat Disord. 2020;43:102154. doi: 10.1016/j.msard.2020.102154.
Corfield F, Langdon D. A systematic review and meta-analysis of the Brief Cognitive Assessment for Multiple Sclerosis (BICAMS). Neurol Ther. 2018;7(2):287–306. doi: 10.1007/s40120-018-0102-3
Lamb SE, Jørstad-Stein EC, Hauer K, Becker C; Prevention of Falls Network Europe and Outcomes Consensus Group. Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus. J Am Geriatr Soc. 2005;53(9):1618–1622. doi: 10.1111/j.1532-5415.2005.53455.x
Middleton A, Fritz SL, Lusardi M. Walking speed: the functional vital sign. J Aging Phys Act. 2015;23(2):314–322. doi: 10.1123/japa.2013-0236
Macaron G, Baldassari LE, Nakamura K, . Cognitive processing speed in multiple sclerosis clinical practice: association with patient-reported outcomes, employment, and magnetic resonance imaging metrics. Eur J Neurol. 2020;27(7):1238–1249. doi: 10.1111/ene.14239
Baetge SJ, Filser M, Renner A, Ullrich S, Lassek C, Penner IK. On the validity of single tests, two-test combinations, and the full Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in detecting patients with cognitive impairment. Mult Scler. 2020;26(14):1919–1928. doi: 10.1177/1352458519887897
Denney DR, Lynch SG, Parmenter BA. A 3-year longitudinal study of cognitive impairment in patients with primary progressive multiple sclerosis: speed matters. J Neurol Sci. 2008;267(1–2):129–136. doi: 10.1016/j.jns.2007.10.007
Kalb R, Beier M, Benedict RH, . Recommendations for cognitive screening and management in multiple sclerosis care. Mult Scler. 2018;24(13):1665–1680. doi: 10.1177/1352458518803785
FINANCIAL DISCLOSURES: Dr Fritz serves on the MS scientific advisory board for Helius Medical. The other authors declare no conflicts of interest.
FUNDING/SUPPORT: None.
PRIOR PRESENTATION: Preliminary data from this manuscript were presented as a poster at the Consortium of Multiple Sclerosis Centers Annual Meeting; October 2021; Orlando, Florida.
A Subspecialty for Half the World’s Population: Women’s Neurology